The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cefotaxime Sodium API Market Outlook 2024
Synopsis
Cefotaxime sodium is the sodium salt form of cefotaxime, a beta-lactam, third-generation cephalosporin antibiotic with bactericidal activity. Cefotaxime sodium binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linking of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis. Compared to the second and first generation cephalosporins, cefotaxime sodium is more active against gram-negative bacteria and less active against gram-positive bacteria.
Market competition is intense. REYOUNG, Nectar Lifesciences, Medya Pharma, Sandoz, Kelun, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accountted for 57.98% market share in 2019.
The global Cefotaxime Sodium API market was valued at US$ 102.1 million in 2020 and is expected to reach US$ 96.4 million by the end of 2027, growing at a CAGR of -0.8% during 2021-2027.
This report focuses on Cefotaxime Sodium API volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cefotaxime Sodium API market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Cefotaxime Sodium API Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
ChP
USP
EP
Segment by Application
Single Injection
Compound Injection
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
REYOUNG
Nectar Lifesciences
Medya Pharma
Sandoz
Kelun
NCPC
Aurobindo Pharma
United Laboratories
Orchid Pharma
CSPC
Kopran
Covalent
ACS Dobfar
Dawnrays
Sterile India
Cefotaxime sodium is the sodium salt form of cefotaxime, a beta-lactam, third-generation cephalosporin antibiotic with bactericidal activity. Cefotaxime sodium binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linking of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis. Compared to the second and first generation cephalosporins, cefotaxime sodium is more active against gram-negative bacteria and less active against gram-positive bacteria.
Market competition is intense. REYOUNG, Nectar Lifesciences, Medya Pharma, Sandoz, Kelun, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accountted for 57.98% market share in 2019.
The global Cefotaxime Sodium API market was valued at US$ 102.1 million in 2020 and is expected to reach US$ 96.4 million by the end of 2027, growing at a CAGR of -0.8% during 2021-2027.
This report focuses on Cefotaxime Sodium API volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cefotaxime Sodium API market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Cefotaxime Sodium API Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
ChP
USP
EP
Segment by Application
Single Injection
Compound Injection
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
REYOUNG
Nectar Lifesciences
Medya Pharma
Sandoz
Kelun
NCPC
Aurobindo Pharma
United Laboratories
Orchid Pharma
CSPC
Kopran
Covalent
ACS Dobfar
Dawnrays
Sterile India
Index1 Cefotaxime Sodium API Market Overview
1.1 Product Overview and Scope of Cefotaxime Sodium API
1.2 Cefotaxime Sodium API Segment by Type
1.2.1 Global Cefotaxime Sodium API Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 ChP
1.2.3 USP
1.2.4 EP
1.3 Cefotaxime Sodium API Segment by Application
1.3.1 Global Cefotaxime Sodium API Sales Comparison by Application: (2021-2027)
1.3.2 Single Injection
1.3.3 Compound Injection
1.4 Global Cefotaxime Sodium API Market Size Estimates and Forecasts
1.4.1 Global Cefotaxime Sodium API Revenue 2016-2027
1.4.2 Global Cefotaxime Sodium API Sales 2016-2027
1.4.3 Cefotaxime Sodium API Market Size by Region: 2016 Versus 2021 Versus 2027
2 Cefotaxime Sodium API Market Competition by Manufacturers
2.1 Global Cefotaxime Sodium API Sales Market Share by Manufacturers (2016-2021)
2.2 Global Cefotaxime Sodium API Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Cefotaxime Sodium API Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Cefotaxime Sodium API Manufacturing Sites, Area Served, Product Type
2.5 Cefotaxime Sodium API Market Competitive Situation and Trends
2.5.1 Cefotaxime Sodium API Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Cefotaxime Sodium API Players Market Share by Revenue
2.5.3 Global Cefotaxime Sodium API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cefotaxime Sodium API Retrospective Market Scenario by Region
3.1 Global Cefotaxime Sodium API Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Cefotaxime Sodium API Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Cefotaxime Sodium API Market Facts & Figures by Country
3.3.1 North America Cefotaxime Sodium API Sales by Country
3.3.2 North America Cefotaxime Sodium API Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Cefotaxime Sodium API Market Facts & Figures by Country
3.4.1 Europe Cefotaxime Sodium API Sales by Country
3.4.2 Europe Cefotaxime Sodium API Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cefotaxime Sodium API Market Facts & Figures by Region
3.5.1 Asia Pacific Cefotaxime Sodium API Sales by Region
3.5.2 Asia Pacific Cefotaxime Sodium API Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Cefotaxime Sodium API Market Facts & Figures by Country
3.6.1 Latin America Cefotaxime Sodium API Sales by Country
3.6.2 Latin America Cefotaxime Sodium API Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Cefotaxime Sodium API Market Facts & Figures by Country
3.7.1 Middle East and Africa Cefotaxime Sodium API Sales by Country
3.7.2 Middle East and Africa Cefotaxime Sodium API Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Cefotaxime Sodium API Historic Market Analysis by Type
4.1 Global Cefotaxime Sodium API Sales Market Share by Type (2016-2021)
4.2 Global Cefotaxime Sodium API Revenue Market Share by Type (2016-2021)
4.3 Global Cefotaxime Sodium API Price by Type (2016-2021)
5 Global Cefotaxime Sodium API Historic Market Analysis by Application
5.1 Global Cefotaxime Sodium API Sales Market Share by Application (2016-2021)
5.2 Global Cefotaxime Sodium API Revenue Market Share by Application (2016-2021)
5.3 Global Cefotaxime Sodium API Price by Application (2016-2021)
6 Key Companies Profiled
6.1 REYOUNG
6.1.1 REYOUNG Corporation Information
6.1.2 REYOUNG Description and Business Overview
6.1.3 REYOUNG Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021)
6.1.4 REYOUNG Cefotaxime Sodium API Product Portfolio
6.1.5 REYOUNG Recent Developments/Updates
6.2 Nectar Lifesciences
6.2.1 Nectar Lifesciences Corporation Information
6.2.2 Nectar Lifesciences Description and Business Overview
6.2.3 Nectar Lifesciences Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Nectar Lifesciences Cefotaxime Sodium API Product Portfolio
6.2.5 Nectar Lifesciences Recent Developments/Updates
6.3 Medya Pharma
6.3.1 Medya Pharma Corporation Information
6.3.2 Medya Pharma Description and Business Overview
6.3.3 Medya Pharma Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Medya Pharma Cefotaxime Sodium API Product Portfolio
6.3.5 Medya Pharma Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Corporation Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sandoz Cefotaxime Sodium API Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 Kelun
6.5.1 Kelun Corporation Information
6.5.2 Kelun Description and Business Overview
6.5.3 Kelun Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Kelun Cefotaxime Sodium API Product Portfolio
6.5.5 Kelun Recent Developments/Updates
6.6 NCPC
6.6.1 NCPC Corporation Information
6.6.2 NCPC Description and Business Overview
6.6.3 NCPC Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021)
6.6.4 NCPC Cefotaxime Sodium API Product Portfolio
6.6.5 NCPC Recent Developments/Updates
6.7 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporation Information
6.6.2 Aurobindo Pharma Description and Business Overview
6.6.3 Aurobindo Pharma Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Aurobindo Pharma Cefotaxime Sodium API Product Portfolio
6.7.5 Aurobindo Pharma Recent Developments/Updates
6.8 United Laboratories
6.8.1 United Laboratories Corporation Information
6.8.2 United Laboratories Description and Business Overview
6.8.3 United Laboratories Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021)
6.8.4 United Laboratories Cefotaxime Sodium API Product Portfolio
6.8.5 United Laboratories Recent Developments/Updates
6.9 Orchid Pharma
6.9.1 Orchid Pharma Corporation Information
6.9.2 Orchid Pharma Description and Business Overview
6.9.3 Orchid Pharma Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Orchid Pharma Cefotaxime Sodium API Product Portfolio
6.9.5 Orchid Pharma Recent Developments/Updates
6.10 CSPC
6.10.1 CSPC Corporation Information
6.10.2 CSPC Description and Business Overview
6.10.3 CSPC Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021)
6.10.4 CSPC Cefotaxime Sodium API Product Portfolio
6.10.5 CSPC Recent Developments/Updates
6.11 Kopran
6.11.1 Kopran Corporation Information
6.11.2 Kopran Cefotaxime Sodium API Description and Business Overview
6.11.3 Kopran Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Kopran Cefotaxime Sodium API Product Portfolio
6.11.5 Kopran Recent Developments/Updates
6.12 Covalent
6.12.1 Covalent Corporation Information
6.12.2 Covalent Cefotaxime Sodium API Description and Business Overview
6.12.3 Covalent Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Covalent Cefotaxime Sodium API Product Portfolio
6.12.5 Covalent Recent Developments/Updates
6.13 ACS Dobfar
6.13.1 ACS Dobfar Corporation Information
6.13.2 ACS Dobfar Cefotaxime Sodium API Description and Business Overview
6.13.3 ACS Dobfar Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021)
6.13.4 ACS Dobfar Cefotaxime Sodium API Product Portfolio
6.13.5 ACS Dobfar Recent Developments/Updates
6.14 Dawnrays
6.14.1 Dawnrays Corporation Information
6.14.2 Dawnrays Cefotaxime Sodium API Description and Business Overview
6.14.3 Dawnrays Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Dawnrays Cefotaxime Sodium API Product Portfolio
6.14.5 Dawnrays Recent Developments/Updates
6.15 Sterile India
6.15.1 Sterile India Corporation Information
6.15.2 Sterile India Cefotaxime Sodium API Description and Business Overview
6.15.3 Sterile India Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Sterile India Cefotaxime Sodium API Product Portfolio
6.15.5 Sterile India Recent Developments/Updates
7 Cefotaxime Sodium API Manufacturing Cost Analysis
7.1 Cefotaxime Sodium API Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cefotaxime Sodium API
7.4 Cefotaxime Sodium API Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cefotaxime Sodium API Distributors List
8.3 Cefotaxime Sodium API Customers
9 Cefotaxime Sodium API Market Dynamics
9.1 Cefotaxime Sodium API Industry Trends
9.2 Cefotaxime Sodium API Growth Drivers
9.3 Cefotaxime Sodium API Market Challenges
9.4 Cefotaxime Sodium API Market Restraints
10 Global Market Forecast
10.1 Cefotaxime Sodium API Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cefotaxime Sodium API by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Cefotaxime Sodium API by Type (2022-2027)
10.2 Cefotaxime Sodium API Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cefotaxime Sodium API by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Cefotaxime Sodium API by Application (2022-2027)
10.3 Cefotaxime Sodium API Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cefotaxime Sodium API by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Cefotaxime Sodium API by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Cefotaxime Sodium API Sales (MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Cefotaxime Sodium API Sales (MT) Comparison by Application (2021-2027)
Table 3. Global Cefotaxime Sodium API Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Cefotaxime Sodium API Covered in This Study
Table 5. Global Cefotaxime Sodium API Sales (MT) of Key Manufacturers (2016-2021)
Table 6. Global Cefotaxime Sodium API Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Cefotaxime Sodium API Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Cefotaxime Sodium API Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Cefotaxime Sodium API Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Cefotaxime Sodium API Manufacturing Sites and Area Served
Table 11. Manufacturers Cefotaxime Sodium API Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Cefotaxime Sodium API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cefotaxime Sodium API as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Cefotaxime Sodium API Sales by Region (2016-2021) & (MT)
Table 16. Global Cefotaxime Sodium API Sales Market Share by Region (2016-2021)
Table 17. Global Cefotaxime Sodium API Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Cefotaxime Sodium API Sales by Country (2016-2021) & (MT)
Table 19. North America Cefotaxime Sodium API Sales Market Share by Country (2016-2021)
Table 20. North America Cefotaxime Sodium API Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Cefotaxime Sodium API Revenue Market Share by Country (2016-2021)
Table 22. Europe Cefotaxime Sodium API Sales by Country (2016-2021) & (MT)
Table 23. Europe Cefotaxime Sodium API Sales Market Share by Country (2016-2021)
Table 24. Europe Cefotaxime Sodium API Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Cefotaxime Sodium API Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Cefotaxime Sodium API Sales by Region (2016-2021) & (MT)
Table 27. Asia Pacific Cefotaxime Sodium API Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Cefotaxime Sodium API Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Cefotaxime Sodium API Revenue Market Share by Region (2016-2021)
Table 30. Latin America Cefotaxime Sodium API Sales by Country (2016-2021) & (MT)
Table 31. Latin America Cefotaxime Sodium API Sales Market Share by Country (2016-2021)
Table 32. Latin America Cefotaxime Sodium API Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Cefotaxime Sodium API Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Cefotaxime Sodium API Sales by Country (2016-2021) & (MT)
Table 35. Middle East and Africa Cefotaxime Sodium API Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Cefotaxime Sodium API Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Cefotaxime Sodium API Revenue Market Share by Country (2016-2021)
Table 38. Global Cefotaxime Sodium API Sales (MT) by Type (2016-2021)
Table 39. Global Cefotaxime Sodium API Sales Market Share by Type (2016-2021)
Table 40. Global Cefotaxime Sodium API Revenue (Million US$) by Type (2016-2021)
Table 41. Global Cefotaxime Sodium API Revenue Share by Type (2016-2021)
Table 42. Global Cefotaxime Sodium API Price (USD/MT) by Type (2016-2021)
Table 43. Global Cefotaxime Sodium API Sales (MT) by Application (2016-2021)
Table 44. Global Cefotaxime Sodium API Sales Market Share by Application (2016-2021)
Table 45. Global Cefotaxime Sodium API Revenue (Million US$) by Application (2016-2021)
Table 46. Global Cefotaxime Sodium API Revenue Share by Application (2016-2021)
Table 47. Global Cefotaxime Sodium API Price (USD/MT) by Application (2016-2021)
Table 48. REYOUNG Corporation Information
Table 49. REYOUNG Description and Business Overview
Table 50. REYOUNG Cefotaxime Sodium API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. REYOUNG Cefotaxime Sodium API Product
Table 52. REYOUNG Recent Developments/Updates
Table 53. Nectar Lifesciences Corporation Information
Table 54. Nectar Lifesciences Description and Business Overview
Table 55. Nectar Lifesciences Cefotaxime Sodium API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Nectar Lifesciences Cefotaxime Sodium API Product
Table 57. Nectar Lifesciences Recent Developments/Updates
Table 58. Medya Pharma Corporation Information
Table 59. Medya Pharma Description and Business Overview
Table 60. Medya Pharma Cefotaxime Sodium API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Medya Pharma Cefotaxime Sodium API Product
Table 62. Medya Pharma Recent Developments/Updates
Table 63. Sandoz Corporation Information
Table 64. Sandoz Description and Business Overview
Table 65. Sandoz Cefotaxime Sodium API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Sandoz Cefotaxime Sodium API Product
Table 67. Sandoz Recent Developments/Updates
Table 68. Kelun Corporation Information
Table 69. Kelun Description and Business Overview
Table 70. Kelun Cefotaxime Sodium API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Kelun Cefotaxime Sodium API Product
Table 72. Kelun Recent Developments/Updates
Table 73. NCPC Corporation Information
Table 74. NCPC Description and Business Overview
Table 75. NCPC Cefotaxime Sodium API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. NCPC Cefotaxime Sodium API Product
Table 77. NCPC Recent Developments/Updates
Table 78. Aurobindo Pharma Corporation Information
Table 79. Aurobindo Pharma Description and Business Overview
Table 80. Aurobindo Pharma Cefotaxime Sodium API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Aurobindo Pharma Cefotaxime Sodium API Product
Table 82. Aurobindo Pharma Recent Developments/Updates
Table 83. United Laboratories Corporation Information
Table 84. United Laboratories Description and Business Overview
Table 85. United Laboratories Cefotaxime Sodium API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. United Laboratories Cefotaxime Sodium API Product
Table 87. United Laboratories Recent Developments/Updates
Table 88. Orchid Pharma Corporation Information
Table 89. Orchid Pharma Description and Business Overview
Table 90. Orchid Pharma Cefotaxime Sodium API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Orchid Pharma Cefotaxime Sodium API Product
Table 92. Orchid Pharma Recent Developments/Updates
Table 93. CSPC Corporation Information
Table 94. CSPC Description and Business Overview
Table 95. CSPC Cefotaxime Sodium API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. CSPC Cefotaxime Sodium API Product
Table 97. CSPC Recent Developments/Updates
Table 98. Kopran Corporation Information
Table 99. Kopran Description and Business Overview
Table 100. Kopran Cefotaxime Sodium API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 101. Kopran Cefotaxime Sodium API Product
Table 102. Kopran Recent Developments/Updates
Table 103. Covalent Corporation Information
Table 104. Covalent Description and Business Overview
Table 105. Covalent Cefotaxime Sodium API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 106. Covalent Cefotaxime Sodium API Product
Table 107. Covalent Recent Developments/Updates
Table 108. ACS Dobfar Corporation Information
Table 109. ACS Dobfar Description and Business Overview
Table 110. ACS Dobfar Cefotaxime Sodium API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 111. ACS Dobfar Cefotaxime Sodium API Product
Table 112. ACS Dobfar Recent Developments/Updates
Table 113. Dawnrays Corporation Information
Table 114. Dawnrays Description and Business Overview
Table 115. Dawnrays Cefotaxime Sodium API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 116. Dawnrays Cefotaxime Sodium API Product
Table 117. Dawnrays Recent Developments/Updates
Table 118. Sterile India Corporation Information
Table 119. Sterile India Description and Business Overview
Table 120. Sterile India Cefotaxime Sodium API Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 121. Sterile India Cefotaxime Sodium API Product
Table 122. Sterile India Recent Developments/Updates
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Cefotaxime Sodium API Distributors List
Table 126. Cefotaxime Sodium API Customers List
Table 127. Cefotaxime Sodium API Market Trends
Table 128. Cefotaxime Sodium API Growth Drivers
Table 129. Cefotaxime Sodium API Market Challenges
Table 130. Cefotaxime Sodium API Market Restraints
Table 131. Global Cefotaxime Sodium API Sales Forecast by Type (2022-2027) & (MT)
Table 132. Global Cefotaxime Sodium API Sales Market Share Forecast by Type (2022-2027)
Table 133. Global Cefotaxime Sodium API Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 134. Global Cefotaxime Sodium API Revenue Market Share Forecast by Type (2022-2027)
Table 135. Global Cefotaxime Sodium API Sales Forecast by Application (2022-2027) & (MT)
Table 136. Global Cefotaxime Sodium API Sales Market Share Forecast by Application (2022-2027)
Table 137. Global Cefotaxime Sodium API Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 138. Global Cefotaxime Sodium API Revenue Market Share Forecast by Application (2022-2027)
Table 139. Global Cefotaxime Sodium API Sales Forecast by Region (2022-2027) & (MT)
Table 140. Global Cefotaxime Sodium API Sales Market Share Forecast by Region (2022-2027)
Table 141. Global Cefotaxime Sodium API Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 142. Global Cefotaxime Sodium API Revenue Market Share Forecast by Region (2022-2027)
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cefotaxime Sodium API
Figure 2. Global Cefotaxime Sodium API Market Share by Type in 2020 & 2027
Figure 3. ChP Product Picture
Figure 4. USP Product Picture
Figure 5. EP Product Picture
Figure 6. Global Cefotaxime Sodium API Market Share by Application in 2020 & 2027
Figure 7. Single Injection
Figure 8. Compound Injection
Figure 9. Global Cefotaxime Sodium API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Cefotaxime Sodium API Market Size 2016-2027 (US$ Million)
Figure 11. Global Cefotaxime Sodium API Sales 2016-2027 (MT)
Figure 12. Global Cefotaxime Sodium API Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Cefotaxime Sodium API Sales Share by Manufacturers in 2020
Figure 14. Global Cefotaxime Sodium API Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Cefotaxime Sodium API Players: Market Share by Revenue in 2020
Figure 16. Cefotaxime Sodium API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Cefotaxime Sodium API Sales Market Share by Region (2016-2021)
Figure 18. Global Cefotaxime Sodium API Sales Market Share by Region in 2020
Figure 19. Global Cefotaxime Sodium API Revenue Market Share by Region (2016-2021)
Figure 20. Global Cefotaxime Sodium API Revenue Market Share by Region in 2020
Figure 21. U.S. Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Cefotaxime Sodium API by Type (2016-2021)
Figure 46. Sales Market Share of Cefotaxime Sodium API by Application (2016-2021)
Figure 47. Sales Market Share of Cefotaxime Sodium API by Application in 2020
Figure 48. Revenue Share of Cefotaxime Sodium API by Application (2016-2021)
Figure 49. Revenue Share of Cefotaxime Sodium API by Application in 2020
Figure 50. Manufacturing Cost Structure of Cefotaxime Sodium API
Figure 51. Manufacturing Process Analysis of Cefotaxime Sodium API
Figure 52. Cefotaxime Sodium API Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
